Vor Biopharma Announces Participation at Cowen 41st Annual Health Care Conference
Vor Biopharma (Nasdaq: VOR), a leader in engineered hematopoietic stem cell (eHSC) therapies for cancer treatment, will participate in the Cowen 41st Annual Health Care Conference from March 1-4, 2021. CEO Robert Ang and CFO Nathan Jorgensen are set to present on March 4 at 1:30 p.m. E.T. The company focuses on developing treatment-resistant transplants that enhance the effectiveness of targeted therapies, allowing for the selective destruction of cancer cells while preserving healthy tissue.
- Participation in Cowen 41st Annual Health Care Conference indicates company engagement with investors.
- Focus on innovative eHSC therapies that enhance targeted cancer treatments.
- None.
CAMBRIDGE, Mass., March 01, 2021 (GLOBE NEWSWIRE) -- Vor Biopharma (Nasdaq: VOR), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced that the Company will be participating in the Cowen 41st Annual Health Care Conference, which will take place virtually on March 1-4, 2021. Robert Ang, MBBS, MBA, Vor’s President and Chief Executive Officer, and Nathan Jorgensen, PhD, Chief Financial Officer, are scheduled to present on Thursday, March 4, 2021, at 1:30 p.m. E.T.
About Vor Biopharma
Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancerous cells while sparing healthy cells.
Contacts:
Investor:
Constantine Davides, CFA
Westwicke
+1 339-970-2846
constantine.davides@westwicke.com
Media:
Mary Carmichael
Ten Bridge Communications
+1 617-413-3543
mary@tenbridgecommunications.com
FAQ
What is Vor Biopharma's focus in cancer treatment?
When is Vor Biopharma presenting at the Cowen Health Care Conference?
Where can I find more information about Vor Biopharma's conference participation?
What is the stock symbol for Vor Biopharma?
